Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs placebo for neurological, infarct size, sleep and cognitive outcomes after ischemic stroke
IRCT201609059566N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in ischemic stroke comparing Melatonin with Placebo (2 arms). Primary endpoints: Neurological complications improvement, Infarct size and 2 more. Started Oct 2016; status: completed.
02
Drugs
melatonin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT201609059566N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201609059566N2.